整合素αvβ8介导的TGF-β1活化调控免疫性血小板减少症停用TPO-RA后的持续应答
研究纳入49例接受TPO-RA治疗4个月的免疫性血小板减少症患者并随访3个月,分为持续应答组21例和非持续应答组28例。持续应答组活化TGF-β1水平显著高于总TGF-β1,整合素αvβ8调控TGF-β1活化并恢复免疫耐受。小鼠实验显示αvβ8激活TGF-β1可延长停用TPO后的缓解,D-甘露糖联合TPO可延长ITP小鼠应答。
要点
- 持续应答组活化TGF-β1为3854±4380 pg/mL,显著高于非持续应答组的943±1500 pg/mL(P<.001)。
- 血小板因子4-TGF-β1条件敲除小鼠持续应答时间短于野生型小鼠,Treg减少且M1/M2巨噬细胞比值升高。
- 外源性αvβ8(250 ng/kg)可激活TGF-β1并延长野生型小鼠停用TPO后的缓解。
核心结论
- 整合素αvβ8介导的TGF-β1活化通路是ITP有前景的治疗靶点,具有较大的临床应用潜力。
研究设计与样本
- 研究纳入49例接受TPO-RA治疗4个月的患者,随访3个月,分为持续应答组(n=21)和非持续应答组(n=28)。
- 建立血小板因子4-TGF-β1条件敲除小鼠的被动ITP模型,并与野生型小鼠比较。
- 将转染慢病毒小干扰RNA或短发夹RNA以调节整合素β8表达的CD4+ T细胞注入接受主动ITP模型的严重联合免疫缺陷小鼠。
主要发现
- 持续应答组活化TGF-β1为3854±4380 pg/mL,非持续应答组为943±1500 pg/mL,持续应答组显著升高(P<.001)。
- 条件敲除小鼠持续应答时间短于野生型小鼠,调节性T细胞减少,M1与M2巨噬细胞比值升高,抗CD41注射后巨核细胞破坏更严重。
- 外源性αvβ8(250 ng/kg)有效激活TGF-β1并延长野生型小鼠停用TPO后的缓解。
- β8过表达增加调节性T细胞并减少巨核细胞损伤。
- TPO-RA通过激活蛋白1家族和Smad家族成员2信号通路调控αvβ8介导的TGF-β1活化;D-甘露糖联合TPO通过上调αvβ8并激活TGF-β1延长ITP小鼠应答。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Only 30% to 50% of patients with immune thrombocytopenia (ITP) exhibit a sustained response upon thrombopoietin receptor agonists (TPO-RA) withdrawal, underscoring the necessity for mechanistic elucidation. We enrolled 49 patients treated with TPO-RA for 4 months and performed a follow-up study for 3 months, classifying them into sustained responders (n = 21), and nonsustained responders (n = 28). Compared with total transforming growth factor β1 (TGF-β1) levels, activated TGF-β1 levels (3854 ± 4380 vs 943 ± 1500 pg/mL; P< .001) were significantly elevated in sustained responders, with integrin αvβ8 regulating TGF-β1 activation and restoring immune tolerance. We established a passive ITP model using platelet factor 4-TGF-β1 conditional knockout (CKO) mice, which exhibited a shorter duration of sustained response than wild-type (WT) mice. CKO mice demonstrated a reduced regulatory T-cell (Treg) population, an increased M1-to-M2 macrophage ratio, and more severe megakaryocyte destruction after anti-CD41 injection. Exogenous administration of αvβ8 (250 ng/kg) effectively activated TGF-β1 and prolonged remission after TPO discontinuation in WT mice. Additionally, CD4+ T cells were transfected with lentiviral small interfering RNA or short hairpin RNA to modulate integrin β8 expression and these were injected into severe combined immunodeficiency mice undergoing an active model of ITP. Results showed that β8 overexpression increased Tregs and reduced megakaryocyte damage. Mechanistically, TPO-RA modulated αvβ8-mediated TGF-β1 activation through the activator protein 1family and Smad family member 2 signaling pathways. Furthermore, D-mannose combined with TPO prolonged the response in ITP mice by upregulating αvβ8 and activating TGF-β1. Overall, the integrin αvβ8-mediated activation of TGF-β1 pathway represents a promising therapeutic target for ITP, with substantial potential for clinical application.
引用
- Mei H, Xu M, Shu J, et al. Integrin αvβ8-mediated TGF-β1 activation regulates the sustained response in immune thrombocytopenia after TPO-RA withdrawal. Blood. 2026. PMID: 41237341. doi:10.1182/blood.2025029769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。